Price T Rowe Associates Inc Iovance Biotherapeutics, Inc. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,102,912 shares of IOVA stock, worth $25.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,102,912

Previous 3,482,402 10.9%

Holding current value

$25.3 Million

Previous $27.9 Million 4.33%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.28 - $11.9 $2.76 Million - $4.52 Million	-379,490 Reduced 10.9%	3,102,912 $29.1 Million
Q2 2024 Aug 14, 2024	SELL	$7.78 - $14.19 $13.9 Million - $25.3 Million	-1,785,462 Reduced 33.89%	3,482,402 $27.9 Million
Q1 2024 May 15, 2024	BUY	$7.59 - $17.47 $15.1 Million - $34.8 Million	1,991,262 Added 60.77%	5,267,864 $78.1 Million
Q4 2023 Feb 14, 2024	SELL	$3.3 - $8.89 $1.06 Million - $2.85 Million	-320,518 Reduced 8.91%	3,276,602 $26.6 Million
Q3 2023 Nov 14, 2023	SELL	$4.44 - $8.79 $294,163 - $582,363	-66,253 Reduced 1.81%	3,597,120 $16.4 Million
Q2 2023 Aug 14, 2023	SELL	$5.36 - $9.06 $495,773 - $838,004	-92,495 Reduced 2.46%	3,663,373 $25.8 Million
Q1 2023 May 15, 2023	SELL	$5.53 - $8.22 $513,532 - $763,333	-92,863 Reduced 2.41%	3,755,868 $22.9 Million
Q4 2022 Feb 14, 2023	SELL	$5.62 - $10.0 $4.85 Million - $8.63 Million	-862,583 Reduced 18.31%	3,848,731 $24.6 Million
Q3 2022 Nov 14, 2022	BUY	$9.53 - $13.11 $3.44 Million - $4.73 Million	360,629 Added 8.29%	4,711,314 $45.1 Million
Q2 2022 Aug 15, 2022	SELL	$6.38 - $18.33 $5.14 Million - $14.8 Million	-805,961 Reduced 15.63%	4,350,685 $48 Million
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $6.1 Million - $9.41 Million	492,861 Added 10.57%	5,156,646 $85.9 Million
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $646,393 - $1.08 Million	39,057 Added 0.84%	4,663,785 $89 Million
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $525,518 - $687,693	-25,824 Reduced 0.56%	4,624,728 $114 Million
Q2 2021 Aug 16, 2021	SELL	$16.33 - $33.07 $7.92 Million - $16 Million	-484,904 Reduced 9.44%	4,650,552 $121 Million
Q1 2021 May 17, 2021	SELL	$28.67 - $52.59 $64.4 Million - $118 Million	-2,246,749 Reduced 30.43%	5,135,456 $163 Million
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $207 Million - $371 Million	7,382,205 New	7,382,205 $343 Million

Others Institutions Holding IOVA

# of Institutions

313

Shares Held

241M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Iovance Biotherapeutics, Inc. Transaction History